Vaidya Sunil R, Kamble Madhukar B, Chowdhury Deepika T, Kumbhar Neelakshi S
WHO Accredited National Measles Reference Laboratory, National Institute of Virology (ICMR), Pune, India.
Indian J Med Res. 2016 Feb;143(2):227-31. doi: 10.4103/0971-5916.180214.
BACKGROUND & OBJECTIVES: Under the outbreak-based measles surveillance in Maharashtra State the National Institute of Virology at Pune receives 3-5 serum samples from each outbreak and samples from the local hospitals in Pune for laboratory diagnosis. This report describes one year data on the measles and rubella serology, virus isolation and genotyping.
Maharashtra State Health Agencies investigated 98 suspected outbreaks between January-December 2013 in the 20 districts. Altogether, 491 serum samples were received from 20 districts and 126 suspected cases from local hospitals. Samples were tested for the measles and rubella IgM antibodies by commercial enzyme immunoassay (EIA). To understand the diagnostic utility, a subset of serum samples (n=53) was tested by measles focus reduction neutralization test (FRNT). Further, 37 throat swabs and 32 urine specimens were tested by measles reverse transcription (RT)-PCR and positive products were sequenced. Virus isolation was performed in Vero hSLAM cells.
Of the 98 suspected measles outbreaks, 61 were confirmed as measles, 12 as rubella and 21 confirmed as the mixed outbreaks. Four outbreaks remained unconfirmed. Of the 126 cases from the local hospitals, 91 were confirmed for measles and three for rubella. Overall, 93.6 per cent (383/409) confirmed measles cases were in the age group of 0-15 yr. Measles virus was detected in 18 of 38 specimens obtained from the suspected cases. Sequencing of PCR products revealed circulation of D4 (n=9) and D8 (n=9) strains. Four measles viruses (three D4 & one D8) were isolated.
INTERPRETATION & CONCLUSIONS: Altogether, 94 measles and rubella outbreaks were confirmed in 2013 in the State of Maharasthra indicating the necessity to increase measles vaccine coverage in the State.
在马哈拉施特拉邦基于疫情的麻疹监测中,浦那的国家病毒学研究所从每次疫情中接收3 - 5份血清样本,并从浦那当地医院接收样本用于实验室诊断。本报告描述了关于麻疹和风疹血清学、病毒分离及基因分型的一年数据。
马哈拉施特拉邦卫生机构在2013年1月至12月期间对20个区的98起疑似疫情进行了调查。共从20个区接收了491份血清样本,从当地医院接收了126例疑似病例。通过商业酶免疫测定法(EIA)检测样本中的麻疹和风疹IgM抗体。为了解诊断效用,对一部分血清样本(n = 53)进行了麻疹空斑减少中和试验(FRNT)检测。此外,对37份咽拭子和32份尿液标本进行了麻疹逆转录(RT)-PCR检测,并对阳性产物进行了测序。在Vero hSLAM细胞中进行病毒分离。
在98起疑似麻疹疫情中,61起被确认为麻疹,12起为风疹,21起被确认为混合疫情。4起疫情仍未得到确认。在当地医院的126例病例中,91例被确认为麻疹,3例为风疹。总体而言,93.6%(383/409)确诊的麻疹病例年龄在0 - 15岁组。从疑似病例中获取的38份标本中有18份检测到麻疹病毒。PCR产物测序显示D4(n = 9)和D8(n = 9)毒株在传播。分离出4株麻疹病毒(3株D4和1株D8)。
2013年马哈拉施特拉邦共确认了94起麻疹和风疹疫情,表明该邦有必要提高麻疹疫苗接种覆盖率。